ImpediMed Limited announce the signing of a Global Strategic Commercial Partnership and pilot program with GenesisCare. The pilot program will consist of an initial roll out of five (5) SOZO® units to establish lymphedema screening services for breast cancer patients in centers across the United States. These units are scheduled to be installed over the coming quarter.

Upon successful completion of the pilot program, GenesisCare will evaluate a staged expansion to additional sites in the United States and globally. GenesisCare focuses on a culture of care that is patient focused and performance driven. Their vision is to provide care that focuses on the individual as well as the condition.

They personalize treatment by designing individualized care experiences that get the best possible life outcomes with a goal of delivering exceptional service in a way that enhances every aspect of a patient's cancer journey. Over the past year, ImpediMed announced a strategy of expanding its engagement with key corporate accounts and large integrated delivery networks (IDNs). As a part of a proven land and expand strategy, SOZO programs start small and then expand once workflows are established.

The Company has almost a quarter of US SOZO's now operating in IDN and corporate accounts and expects this number to significantly grow as reimbursement becomes widely available.